|
|
 Insulin Information - December 2, 2008
| Cleveland researchers have found that the widely used diabetes pill Actos appears to lower a patient's chances of death by a heart attack or stroke, unlike its close competitor Avandia. However, Actos also carries an increased risk of nonfatal heart failure, the analysis showed, confirming earlier studies. Researchers analyzed 19 clinical trials of the drug Actos and concluded that the medicine carries cardiovascular benefits not seen in other diabetes drugs | | The number of serious injuries and deaths reported to the U.S. Food and Drug Administration from widely used medicines almost tripled between 1998 and 2005, an analysis of U.S. drug data found. The report in Monday's Archives of Internal Medicine, published by the American Medical Association, says that the number of deaths and serious injuries from prescription and over-the-counter drugs climbed from 34,966 to 89,842 | | Babies born to mothers diagnosed with gestational diabetes have nearly double the risk of becoming obese during by age 5 to 7, a new study has found. The research also added that if the expectant mothers followed a special diet, exercised or were given insulin, the risk of obese babies disappeared | | The U.S. Food and Drug Administration (FDA) on Thursday advised doctors that patients' genetic makeup can affect how they respond to the widely prescribed blood thinner warfarin, sold under the brand name Coumadin. The federal agency also announced a labeling update for the drug saying such screenings could prevent many complications each year. A research has indicated that the response to the blood-thinning drug depends on a patient's variants of the genes CYP2C9 and VKORC1 that determine how fast warfarin is metabolized | | Free Wooden Picture Frame
http://lantus.complimentarypictureframe.com/
Register to receive more information on insulin and managing your blood sugar. Do it today and receive a FREE Picture Frame | |
|
|